260 / 492
08:18 - 08:21
S21-2
(PP)
A NEW SCORRING SYSTEM TO DETERMINE THE SEVERITY AND THERAPEUTIC
SUCCESS OF BLADDER BOWEL DYSFUNCTION IN CHILDREN
Abdurrahman ONEN
Onen Pediatric Urology Centre, Paediatric Surgery, Diyarbakir, TURKEY
INTRODUCTION
There is still a lack in determining the detailed association of bladder bowel dysfunction(BBD). The evaluation and
follow-up of the patients are mainly based on DVSS, which has been modified from prostate symptom scale for adults.
Here, we aimed to assess the effectiveness of our BBD symptom scale in determining the severity and therapeutic
success and follow-up of these children.
PATIENTS AND METHODS
A total of 214children treated for BBD between 2011and2014 were reviewed prospectively. 164 completed study. The
severity of BBD was determined according to a new BBDSS, Ferhat's DVSS, DESscale, ultrasound and uroflow-EMG. The
patient receives interpretation of data in regards of voiding and defecation habits such as bladder and bowel storage
dysfunction, nocturnal polyuria, constipation and additional symptoms. A score of <10 was accepted as mild, 10-20 as
moderate, and >20 as severe BBDSS score. Non-invasive tests were repeated in the 3rd, 6th month and 1st year of
treatment. Mean follow-up was 2.1years.
RESULTS
Mean age was 8.1 years, 94 were girl and 72 were boy. Total BBD symptom score was 17.2, while it decreased to 4.7
after one-year-treatment. Bladder ultrasound and uroflow-EMG findings were parallel to that of our BBDSS. BBDSS was
<5 in 126children, 5-10 in 30, and >10 in the remaining 8patients after one-year-treatment.
CONCLUSIONS
The Onen BBDSS, which is a simple non-invasive diagnostic tool to patients and their parents, supports diagnosis and
severity of lower urinary tract disorders and association of defecation disorders in a time-effective manner. Not only our
scale promises an effective treatment and high success accordingly but also it determines the effectiveness of
urotherapy during the follow-up period of such patients.